Pacira settles Exparel patent cases, grants Fresenius phased license for generic sales beginning in 2030, with full access no ...

The trial is designed to assess LP-310’s tolerability, preliminary efficacy, and safety in adults with symptomatic OLP.

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a ...

The Gwyneth Paltrow-approved choice for cellular health - To combat stress and toxin exposure, phospholipids have been ...

GenuinePurity™ Liposomal NMN uses liposomal technology for enhanced absorption and is manufactured with 96% purity by Leading ...